Abstract:BACKGROUND: Transanal total mesorectal excision is a promising surgical procedure for mid to low rectal cancer. OBJECTIVE: This study aimed to determine the short-term outcomes of Chinese patients treated with transanal total mesorectal excision. DESIGN: This was an observational study using data from an online registry system. SETTING: Study participants were recruited from 40 different centers across 15 provinces in China. PATIENTS: Patients with either benign or malignant rectal disease who underwent transanal total mesorectal excision procedure and were registered in the Chinese Transanal Total Mesorectal Excision Registry Collaborative from May 2010 to November 2019 were included. INTERVENTION: Patients underwent transanal total mesorectal excision. MAIN OUTCOME MEASURES: The primary outcomes measured were the postoperative complications and pathological outcomes. RESULTS: In total, 1283 patients, comprising 888 men (69.2%) and 395 women (39.8%) with a median age of 61 (22-92) years and a median BMI of 23.6 (14.5-46.3) kg/m(2), were analyzed. Among 40 participating centers, the average number of registered cases was 32.1 +/- 34.7, and 12 centers (30%) registered >40 cases in the registry. Among 849 patients with rectal cancer who underwent laparoscopic-assisted transanal total mesorectal excision, the conversion rate was 0.5% in the abdominal phase and 1.9% in the perineal phase. Three patients reported urethral injury (0.5%). The postoperative complication rate and the anastomotic leakage incidence were 18.4% and 5.8%. The quality of the total mesorectum excision specimens was found to be complete in 81.9% of patients. In addition, the positive circumferential resection margin rate was 2.8%. LIMITATIONS: The primary limitation of this registry study was the high percentage of missing data (10.8% overall), and, for some of the analyzed variables, up to 35% of the data was missing. Postoperative complications were not monitored after discharge, resulting in a lower morbidity rate than the 30-day morbidity rate reported in other studies. CONCLUSIONS: The short-term outcomes of patients who underwent transanal total mesorectal excision procedures in China were acceptable. See Video Abstract at http://links.lww.com/DCR/B414.

Oncologic outcomes following transanal total mesorectal excision: the United States experience

The application of laparoscopic total mesorectal excision with preservation of anal sphincter for rectal cancer

Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer

Transanal total mesorectal excision: short- and long-term results of four certified colorectal cancer centers in Germany

Transanal Total Mesorectal Excision for Rectal Cancer: a Multicentric Cohort Study.

Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients

A systematic review and meta‐analysis of oncological outcomes with transanal total mesorectal excision for rectal cancer

Evolution of transanal total mesorectal excision for rectal cancer: From top to bottom

Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results

Oncological monitoring after transanal total mesorectal excision (TaTME) for rectal neoplasia

The role of transanal total mesorectal excision in the treatment of rectal cancer: a systematic review

[Current status and prospect of transanal total mesorectal excision].

Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial

Oncological and functional outcomes of transanal total mesorectal excision in a teaching hospital in the Netherlands

Oncologic safety and technical feasibility of completion transanal total mesorectal excision after local excision; a cohort study from the International TaTME Registry

Transanal Total Mesorectal Excision: Short-term Outcomes of 1283 Cases from a Nationwide Registry in China.

Pathological outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a systematic review with meta-analysis

Local Recurrence-Free Survival After TaTME: A Canadian Institutional Experience

Clinical Status and Future Prospects of Transanal Total Mesorectal Excision

The surgical skills and outcomes evaluation of transanal total mesorectal excision

Long-term outcomes of transanal total mesorectal excision for rectal cancer: what could we do to improve them?